Skip to main content

Advertisement

SpringerLink
Log in

Reduced Bone Density in Patients with Autosomal Dominant Hyper-IgE Syndrome

  • Original Research
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Background and Purpose

Autosomal dominant hyper-IgE syndrome (AD-HIES) is a rare primary immunodeficiency disorder . It has been recognized as a multisystem disorder and is characterized by both immunologic and non-immunologic manifestations. Possible bone involvement in autosomal dominant HIES include fractures, scoliosis, cystic bone changes, and osteopenia. We sought to evaluate the changes in bone density in adolescents and young adults with AD-HIES, mostly with proven STAT3 mutation, followed in our institute.

Methods

We studied eight patients with AD-HIES who attended our immunology clinic. All patients underwent at least one bone mass dual-energy x-ray absorptiometry assessment (dual-energy x-ray absorptiometry scan).These findings were evaluated.

Results

The age of the patients at the time of their first bone density scan ranged between 10 and 24 years (mean 16.1 ± 4.0 years); the duration of follow-up was 4–11 years (mean 5.8 ± 3.5 years). Four patients had a history of fractures. Mean Z score in these patients was −1.8 ± 0.7. For three patients, Z score was below −1. The other four patients had no history of fractures. Mean Z score in these patients was −0.9 ± 0.5. Only one patient in this group had a Z score below −1. Bone density was below average in all patients; mean spinal Z score was −1.6 ± 0.4. Four patients were followed through the second decade, and all showed progressive deterioration in bone density. Three were treated with alendronate sodium, with improvement in the bone scan results.

Conclusions

Bone density decreases considerably over time in adolescents and young adults suffering from AD- HIES. Treatment with alendronate sodium may be effective in alleviating osteopenia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Davis SD, Schaller J, Wedgwood RJ. Job’s Syndrome. Recurrent, “cold”, staphylococcal abscesses. Lancet. 1966;1:1013–5.

    Article  PubMed  CAS  Google Scholar 

  2. Buckley R, Wray B, Belmaker E. Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. Pediatrics. 1972;49:59–70.

    PubMed  CAS  Google Scholar 

  3. Grimbacher B, Holland SM, Gallin JI, Greenberg F, Hill SC, Malech HL, et al. Hyper-IgE syndrome with recurrent infections – an autosomal dominant multisystem disorder. N Engl J Med. 1999;340:692–702.

    Article  PubMed  CAS  Google Scholar 

  4. Leung DY, Geha RS. Clinical and immunologic aspects of the hyperimmunoglobulin E syndrome. Hematol Oncol Clin North Am. 1988;2:81–100.

    PubMed  CAS  Google Scholar 

  5. Blum R, Geller G, Fish LA. Recurrent severe staphylococcal infections, eczematoid rash: extreme elevations of IgE, eosinophilia and different chemotactic responses in two generations. J Pediatr. 1977;90:607–9.

    Article  PubMed  CAS  Google Scholar 

  6. Holland SM, DeLeo FR, Elloumi HZ, Hsu AP, Uzel G, Brodsky N, et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med. 2007;357:1608–19.

    Article  PubMed  CAS  Google Scholar 

  7. Minegishi Y, Saito M, Tsuchiya S, Tsuge I, Takada H, Hara T, et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature. 2007;448:1058–62.

    Article  PubMed  CAS  Google Scholar 

  8. Freeman AF, Holland SM. The hyper-IgE syndromes. Immunol Allergy Clin North Am. 2008;28:277–91.

    Article  PubMed  Google Scholar 

  9. Milner JD, Brenchley JM, Laurence A, Freeman AF, Hill BJ, Elias KM, et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature. 2008;452:773–6.

    Article  PubMed  CAS  Google Scholar 

  10. Borgess WG, Hensley T, Carey JC, Petrak BA, Hill HR. The face of Job. J Pediatr. 1998;133:303–5.

    Article  Google Scholar 

  11. Osteoporosis prevention, diagnosis and therapy. NIH consensus statement. [No authors listed] 2000;17:1–45.

    Google Scholar 

  12. Uziel Y, Zifman E, Hashkes PJ. Osteoporosis in children: pediatric and pediatric rheumatology perspective: a review. Pediatr Rheumatol Online J. 2009;7:16.

    Article  PubMed  Google Scholar 

  13. Gunes AM, Can E, Saglam H, Ilçöl YO, Baytan B. Assessment of bone mineral density and risk factors in children completing treatment for acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2010;32:e102–7.

    Article  PubMed  CAS  Google Scholar 

  14. Samson F, Cagnard B, Leray E, Guggenbuhl P, Bridoux-Henno L, Dabadie A. Longitudinal study of bone mineral density in children after a diagnosis of Crohn’s disease. Gastroenterol Clin Biol. 2010;334:554–61.

    Article  Google Scholar 

  15. Gordon CM, Bachrach LK, Carpenter TO, Crabtree N, El-Hajj Fuleihan G, Kutilek S, et al. Dual energy x-ray absorptiometry interpretation and reporting in children and adolescents: the 2007 ISCD pediatric official positions. J Clin Densitom. 2008;11:43–58.

    Article  PubMed  Google Scholar 

  16. Schimke LF, Sawalle-Belohradsky J, Roesler J, Wollenberg A, Rack A, Borte M, et al. Diagnostic approach to the hyper-IgE syndromes: Immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis. J Allergy Clin Immunol. 2010;126:611–7.

    Article  PubMed  CAS  Google Scholar 

  17. Baim S, Leonard MB, Bianchi ML, Hans DB, Kalkwarf HJ, Langman CB, et al. Official positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Pediatric Position Development Conference. J Clin Densitorm. 2008;11:6–21.

    Article  Google Scholar 

  18. Bachrach LK, Sills IN. Section on Endocrinology. Clinical report – bone densitometry in children and adolescents. Pediatrics. 2011;127:189–94.

    Article  PubMed  Google Scholar 

  19. Grimbacher B, Schäffer AA, Holland SM, Davis J, Gallin JI, Malech HL, et al. Genetic linkage of hyper-IgE syndrome to chromosome 4. Am J Hum Genet. 1999;65:735–44.

    Article  PubMed  CAS  Google Scholar 

  20. Zhang Z, Elte T, Troiano N, Maher SE, Fu XY, Bothwell AL. Osteoporosis with increased osteoclastogenesis in hematopoietic cell-specific STAT3-deficient mice. Biochem Biophys Res Commun. 2005;328:800–7.

    Article  PubMed  CAS  Google Scholar 

  21. Woellner C, Gertz EM, Schäffer AA, Lagos M, Perro M, Glocker EO, et al. Mutations in STAT3 and diagnostic guidelines for hyper-IgE. J Allergy Clin Immunol. 2009;125:424–32.

    Article  Google Scholar 

  22. Paulson ML, Freeman AF, Holland SM. Hyper IgE syndrome: an update on clinical aspects and the role of signal transducer and activator of transcription 3. Curr Opin Allergy Clin Immunol. 2008;8:527–33.

    Article  PubMed  CAS  Google Scholar 

  23. Shaw NJ. Management of osteoporosis in children. Eur J Endocrinol. 2008;159:533–9.

    Article  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Pediatrics B and Kipper Institute of Allergy and Immunology, Schneider Children’s Medical Center of Israel, Sackler Faculty of Medicine, Tel Aviv University, Petach Tikva, 49202, Israel

    Oded Scheuerman, Vered Hoffer, Avner Herman Cohen & Ben-Zion Garty

  2. Centre of Chronic Immunodeficiency, University Hospital Freiburg, Freiburg, Germany

    Cristina Woellner & Bodo Grimbacher

Authors
  1. Oded Scheuerman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vered Hoffer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Avner Herman Cohen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Cristina Woellner
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Bodo Grimbacher
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ben-Zion Garty
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Oded Scheuerman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Scheuerman, O., Hoffer, V., Cohen, A.H. et al. Reduced Bone Density in Patients with Autosomal Dominant Hyper-IgE Syndrome. J Clin Immunol 33, 903–908 (2013). https://doi.org/10.1007/s10875-013-9895-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-013-9895-0

Keywords

Search

Navigation